logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Fredrik Öberg

science for life laboratory
H指数:26
被引数:2,895

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation

组合性DNMTs和EZH2抑制重编程了H3K27me3和DNAme介导的癌表观基因组，以抑制多发性骨髓瘤增殖

Scientific Reports
IF3.9
2025-08-270
OAAI
Alba Atienza Párraga; Patrick Nylund; Klev Diamanti; Berta Garrido-Zabala; Stefania Iliana Tziola; Louella Vasquez; Paul Theodor Pyl; Doroteya Raykova; Aron Skaftason; Anqi Ma; Jian Jin; José Ignacio Martín-Subero; Fredrik Öberg; Elke De Bruyne; Jan Komorowski; Helena Jernberg Wiklund; Antonia Kalushkova
Dual targeting of G9a and DNMTs induces anti-tumour effects in multiple myeloma

同时靶向G9a和DNMTs在多发性骨髓瘤中诱导抗肿瘤效应

Blood Advances
IF7.1
2025-07-210
OAAI
Patrick Nylund; Berta Garrido-Zabala; Stefania Iliana Tziola; Tabassom Mohajershojai; Hanna Berglund; Catharina Muylaert; Lien Ann Van Hemelrijck; Alba Atienza Párraga; Louella Vasquez; Jim Jacob; Eric Bergquist; José Ignacio Martín-Subero; Fredrik Öberg; Torbjörn Karlsson; Marika Nestor; Elke De Bruyne; Antonia Kalushkova; Helena Jernberg Wiklund
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
JOURNAL OF HEPATOCELLULAR CARCINOMA
IF3.4
2024-10-010
OAAI
Plummer, Ruth; Greystoke, Alastair; Naylor, Gregory; Sarker, Debashis; Anam, A. N. M. Kaiser; Prenen, Hans; Teuwen, Laure-Anne; Van Cutsem, Eric; Dekervel, Jeroen; Haugk, Beate; Ness, Thomas; Bhoi, Sujata; Jensen, Malene; Morris, Tom; Baumann, Pia; Sjogren, Niclas; Tunblad, Karin; Wallberg, Hans; Oberg, Fredrik; Evans, Thomas R. Jeffry
Fostrox (fostroxacitabine bralpamide) plus lenvatinib in patients with locally advanced unresectable or metastatic hepatocellular carcinoma (HCC) progressed on immunotherapy combinations: Results from a multi-center phase Ib/IIa study

Fostrox（fostroxacitabine bralpamide）联合仑伐替尼治疗既往接受免疫联合疗法后进展的局部晚期不可切除或转移性肝细胞癌（HCC）患者：一项多中心 Ib/IIa 期研究的结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Chon, H.; Heo, J.; Evans, T. R. J.; Kim, D. Y.; Lim, H. Y.; Macarulla Mercade, T.; Gomez Martin, C.; Moreno Garcia, V.; Ryu, M. H.; Baumann, P.; Bhoi, S.; Jensen, M.; Tunblad, K.; Wallberg, H.; Oberg, F. G.; Reig Monzon, M. E.

研究方向

暂未获取到该数据
K
Karin Tunblad
H 指数:13论文数:52被引数:671
M
Mark R. Albertella
H 指数:18论文数:193被引数:2,842
S
Sujata Bhoi
H 指数:8论文数:42被引数:323
A
Antonia Kalushkova
H 指数:10论文数:65被引数:462
H
Helena Jernberg‐Wiklund
H 指数:29论文数:147被引数:2,610
H
Hans Wallberg
H 指数:14论文数:47被引数:508
P
Patrick Nylund
H 指数:4论文数:13被引数:55
M
Malene Ringkjøbing Jensen
H 指数:51论文数:172被引数:8,399
L
Linda Rickardson
H 指数:19论文数:37被引数:1,361
A
Alba Atienza Párraga
H 指数:6论文数:12被引数:283